Sensitized signalling between L-type Ca2+ channels and ryanodine receptors in the absence or inhibition of FKBP12.6 in cardiomyocytes

Cardiovasc Res. 2017 Mar 1;113(3):332-342. doi: 10.1093/cvr/cvw247.

Abstract

Aims: The heart contraction is controlled by the Ca2+-induced Ca2+ release (CICR) between L-type Ca2+ channels and ryanodine receptors (RyRs). The FK506-binding protein FKBP12.6 binds to RyR subunits, but its role in stabilizing RyR function has been debated for long. Recent reports of high-resolution RyR structure show that the HD2 domain that binds to the SPRY2 domain of neighbouring subunit in FKBP-bound RyR1 is detached and invisible in FKBP-null RyR2. The present study was to test the consequence of FKBP12.6 absence on the in situ activation of RyR2.

Methods and results: Using whole-cell patch-clamp combined with confocal imaging, we applied a near threshold depolarization to activate a very small fraction of LCCs, which in turn activated RyR Ca2+ sparks stochastically. FKBP12.6-knockout and FK506/rapamycin treatments increased spark frequency and LCC-RyR coupling fidelity without altering LCC open probability. Neither FK506 nor rapamycin further altered LCC-RyR coupling fidelity in FKBP12.6-knockout cells. In loose-seal patch-clamp experiments, the LCC-RyR signalling kinetics, indexed by the delay for a LCC sparklet to trigger a RyR spark, was accelerated after FKBP12.6 knockout and FK506/rapamycin treatments. These results demonstrated that RyRs became more sensitive to Ca2+ triggers without FKBP12.6. Isoproterenol (1 μM) further accelerated the LCC-RyR signalling in FKBP12.6-knockout cells. The synergistic sensitization of RyRs by catecholaminergic signalling and FKBP12.6 dysfunction destabilized the CICR system, leading to chaotic Ca2+ waves and ventricular arrhythmias.

Conclusion: FKBP12.6 keeps the RyRs from over-sensitization, stabilizes the potentially regenerative CICR system, and thus may suppress the life-threatening arrhythmogenesis.

Keywords: Calcium signalling; Excitation-contraction coupling; FK506-binding protein; Ryanodine receptor.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arrhythmias, Cardiac / genetics
  • Arrhythmias, Cardiac / metabolism*
  • Arrhythmias, Cardiac / physiopathology
  • Arrhythmias, Cardiac / prevention & control
  • Calcium Channels, L-Type / chemistry
  • Calcium Channels, L-Type / drug effects
  • Calcium Channels, L-Type / metabolism*
  • Calcium Signaling* / drug effects
  • Genotype
  • Isoproterenol / pharmacology
  • Kinetics
  • Male
  • Membrane Potentials
  • Mice, Knockout
  • Microscopy, Confocal
  • Models, Molecular
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Patch-Clamp Techniques
  • Phenotype
  • Protein Binding
  • Protein Interaction Domains and Motifs
  • Receptor Cross-Talk* / drug effects
  • Ryanodine Receptor Calcium Release Channel / chemistry
  • Ryanodine Receptor Calcium Release Channel / drug effects
  • Ryanodine Receptor Calcium Release Channel / metabolism*
  • Sirolimus / pharmacology
  • Stochastic Processes
  • Tacrolimus / pharmacology
  • Tacrolimus Binding Proteins / antagonists & inhibitors
  • Tacrolimus Binding Proteins / chemistry
  • Tacrolimus Binding Proteins / deficiency*
  • Tacrolimus Binding Proteins / genetics

Substances

  • Calcium Channels, L-Type
  • FKBP12.6 protein, mouse
  • Ryanodine Receptor Calcium Release Channel
  • ryanodine receptor 2. mouse
  • Tacrolimus Binding Proteins
  • Isoproterenol
  • Sirolimus
  • Tacrolimus